Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

CompletedOBSERVATIONAL
Enrollment

1,478

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Venous Thromboembolism
Trial Locations (7)

Unknown

Kantonsspital, Baden

University Hospitals, Bern

Cantonal Hospital, Fribourg

University Hospitals, Geneva

Kantonsspital, Lüzern

Cantonal Hospital, Sankt Gallen

University Hospital, Zurich

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

Kantonsspital Baden

OTHER

collaborator

University of Zurich

OTHER

collaborator

Luzerner Kantonsspital

OTHER

collaborator

Cantonal Hospital of St. Gallen

OTHER

collaborator

Sanofi

INDUSTRY

lead

University Hospital, Geneva

OTHER

NCT01277536 - Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland | Biotech Hunter | Biotech Hunter